Serum prolidase activity, oxidative stress, and antioxidant enzyme levels in patients with prostate cancer
| dc.contributor.author | Kaba, Mehmet | |
| dc.contributor.author | Pirincci, Necip | |
| dc.contributor.author | Demir, Halit | |
| dc.contributor.author | Verep, Samed | |
| dc.date.accessioned | 2026-08-12T17:38:40Z | |
| dc.date.issued | 2024 | |
| dc.department | Fırat Üniversitesi | |
| dc.description.abstract | Objectives: We aimed to identify serum prolidase activity, oxidative stress, and antioxidant enzyme levels in patients with prostate cancers and to evaluate their relationships with each other. Materials and methods: A total of 34 male patients with prostate cancer and with a mean age of 64.2 +/- 4.4 were included in the study. The control group comprising 36 male patients (mean age 61.2 +/- 3.4) was randomly selected among the volunteers. Serum samples for measurement of superoxide dismutase (SOD), glutathione peroxidase (GPx), Catalase (CAT), malondialdehyde (MDA), glutathione (GSH), and prolidase levels were kept at -20 & ring;C until they were used. Results: Serum prolidase activity and MDA levels were significantly higher in prostate cancer patients than in controls (all, P < 0.05), while SOD, GPx, and CAT levels were significantly lower (P < 0.05). Conclusion: Our results indicate that increased prolidase seems to be related to increased oxidative stress along with decreased antioxidant levels in prostate cancer. (c) 2024 Elsevier Inc. All rights reserved. | |
| dc.identifier.doi | 10.1016/j.urolonc.2024.01.007 | |
| dc.identifier.endpage | 1,16e+17 | |
| dc.identifier.issn | 1078-1439 | |
| dc.identifier.issn | 1873-2496 | |
| dc.identifier.issue | 4 | |
| dc.identifier.orcid | 0000-0002-1086-6380 | |
| dc.identifier.pmid | 38341363 | |
| dc.identifier.scopus | 2-s2.0-85184780002 | |
| dc.identifier.scopusquality | Q1 | |
| dc.identifier.startpage | 1,16e+11 | |
| dc.identifier.uri | https://doi.org/10.1016/j.urolonc.2024.01.007 | |
| dc.identifier.uri | https://hdl.handle.net/11508/58533 | |
| dc.identifier.volume | 42 | |
| dc.identifier.wos | WOS:001225886100001 | |
| dc.identifier.wosquality | Q2 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | PubMed | |
| dc.language.iso | en | |
| dc.publisher | Elsevier Science Inc | |
| dc.relation.ispartof | Urologic Oncology-Seminars and Original Investigations | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.snmz | KA_WoS_20260511 | |
| dc.subject | Prostate cancer | |
| dc.subject | Prolidase activity | |
| dc.subject | Antioxidant enzyme | |
| dc.title | Serum prolidase activity, oxidative stress, and antioxidant enzyme levels in patients with prostate cancer | |
| dc.type | Article |







